Synchronous, but separate, bladder and vaginal rhabdomyosarcoma

A novel genetic case report

Bradley Andrew Morganstern, Samantha Scaccia, Wayland Wu, Alex K. Williamson, Lane S. Palmer

Research output: Contribution to journalArticle

Abstract

Embryonal rhabdomyosarcoma is a rare cancer that often requires multimodality therapy to treat; however, these therapies can cause changes in the biology of the tumor. Several reports have documented pathologic changes but only recently have genetic changes been mapped. We present case of two separate synchronous primary rhabdomyosarcomas in a 17-month-old patient and discuss the pathophysiology and genetic changes that occur with treatment. We hypothesize that a genetic field defect arising in development of the urogenital sinus caused the tumors, but that treatment modalities may have caused genetic alterations changing clinical behavior of the tumors and responses to treatment.

Original languageEnglish (US)
Pages (from-to)9357-9359
Number of pages3
JournalCanadian Journal of Urology
Volume25
Issue number3
StatePublished - Jun 1 2018
Externally publishedYes

Fingerprint

Rhabdomyosarcoma
Urinary Bladder
Neoplasms
Embryonal Rhabdomyosarcoma
Therapeutics

Keywords

  • Cystectomy
  • Genetics
  • Pediatric urology
  • Rhabdomyosarcoma
  • Vaginectomy

ASJC Scopus subject areas

  • Urology

Cite this

Synchronous, but separate, bladder and vaginal rhabdomyosarcoma : A novel genetic case report. / Morganstern, Bradley Andrew; Scaccia, Samantha; Wu, Wayland; Williamson, Alex K.; Palmer, Lane S.

In: Canadian Journal of Urology, Vol. 25, No. 3, 01.06.2018, p. 9357-9359.

Research output: Contribution to journalArticle

Morganstern, BA, Scaccia, S, Wu, W, Williamson, AK & Palmer, LS 2018, 'Synchronous, but separate, bladder and vaginal rhabdomyosarcoma: A novel genetic case report', Canadian Journal of Urology, vol. 25, no. 3, pp. 9357-9359.
Morganstern, Bradley Andrew ; Scaccia, Samantha ; Wu, Wayland ; Williamson, Alex K. ; Palmer, Lane S. / Synchronous, but separate, bladder and vaginal rhabdomyosarcoma : A novel genetic case report. In: Canadian Journal of Urology. 2018 ; Vol. 25, No. 3. pp. 9357-9359.
@article{4a4100cfdc3e4b29aadcec59e1b33a8b,
title = "Synchronous, but separate, bladder and vaginal rhabdomyosarcoma: A novel genetic case report",
abstract = "Embryonal rhabdomyosarcoma is a rare cancer that often requires multimodality therapy to treat; however, these therapies can cause changes in the biology of the tumor. Several reports have documented pathologic changes but only recently have genetic changes been mapped. We present case of two separate synchronous primary rhabdomyosarcomas in a 17-month-old patient and discuss the pathophysiology and genetic changes that occur with treatment. We hypothesize that a genetic field defect arising in development of the urogenital sinus caused the tumors, but that treatment modalities may have caused genetic alterations changing clinical behavior of the tumors and responses to treatment.",
keywords = "Cystectomy, Genetics, Pediatric urology, Rhabdomyosarcoma, Vaginectomy",
author = "Morganstern, {Bradley Andrew} and Samantha Scaccia and Wayland Wu and Williamson, {Alex K.} and Palmer, {Lane S.}",
year = "2018",
month = "6",
day = "1",
language = "English (US)",
volume = "25",
pages = "9357--9359",
journal = "Canadian Journal of Urology",
issn = "1195-9479",
publisher = "Canadian Journal of Urology",
number = "3",

}

TY - JOUR

T1 - Synchronous, but separate, bladder and vaginal rhabdomyosarcoma

T2 - A novel genetic case report

AU - Morganstern, Bradley Andrew

AU - Scaccia, Samantha

AU - Wu, Wayland

AU - Williamson, Alex K.

AU - Palmer, Lane S.

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Embryonal rhabdomyosarcoma is a rare cancer that often requires multimodality therapy to treat; however, these therapies can cause changes in the biology of the tumor. Several reports have documented pathologic changes but only recently have genetic changes been mapped. We present case of two separate synchronous primary rhabdomyosarcomas in a 17-month-old patient and discuss the pathophysiology and genetic changes that occur with treatment. We hypothesize that a genetic field defect arising in development of the urogenital sinus caused the tumors, but that treatment modalities may have caused genetic alterations changing clinical behavior of the tumors and responses to treatment.

AB - Embryonal rhabdomyosarcoma is a rare cancer that often requires multimodality therapy to treat; however, these therapies can cause changes in the biology of the tumor. Several reports have documented pathologic changes but only recently have genetic changes been mapped. We present case of two separate synchronous primary rhabdomyosarcomas in a 17-month-old patient and discuss the pathophysiology and genetic changes that occur with treatment. We hypothesize that a genetic field defect arising in development of the urogenital sinus caused the tumors, but that treatment modalities may have caused genetic alterations changing clinical behavior of the tumors and responses to treatment.

KW - Cystectomy

KW - Genetics

KW - Pediatric urology

KW - Rhabdomyosarcoma

KW - Vaginectomy

UR - http://www.scopus.com/inward/record.url?scp=85048612437&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048612437&partnerID=8YFLogxK

M3 - Article

VL - 25

SP - 9357

EP - 9359

JO - Canadian Journal of Urology

JF - Canadian Journal of Urology

SN - 1195-9479

IS - 3

ER -